Exact Mass: 508.2243106
Exact Mass Matches: 508.2243106
Found 500 metabolites which its exact mass value is equals to given mass value 508.2243106
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Argatroban
C23H36N6O5S (508.24677660000003)
Argatroban is a direct, selective thrombin inhibitor. The American College of Cardiologists (ACC) recommend using bivalirudin or argatroban in patients who have had, or at risk for, heparin induced thrombocytopenia (HIT) and are undergoing percutaneous coronary intervention. Argatroban is a non-heparin anticoagulant shown to both normalize platelet count in patients with HIT and prevent the formation of thrombi. Parental anticoagulants must be stopped and a baseline activated partial thromboplastin time must be obtained prior to administering argatroban. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Difluprednate
C27H34F2O7 (508.22724780000004)
Difluprednate is only found in individuals that have used or taken this drug. It is a topical corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery. It was approved by the US Food and Drug Administration (FDA) on June 24, 2008. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins (lipocortins). It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Same as: D01266 Difluprednate is a topical corticosteroid, which is thought to act by the induction of phospholipase A2 inhibitory proteins (lipocortins). Difluprednate is used for the symptomatic treatment of inflammation and pain associated with ocular surgery.
PD 123319
C31H32N4O3 (508.24742819999994)
D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
Argatroban
C23H36N6O5S (508.24677660000003)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AE - Direct thrombin inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Mozambioside
Mozambioside is found in coffee and coffee products. Mozambioside is isolated from beans of arabica coffee (Coffea arabica) and wild coffee sp. (Coffea pseudozanguebariae). Isolated from beans of arabica coffee (Coffea arabica) and wild coffee species (Coffea pseudozanguebariae). Mozambioside is found in coffee and coffee products.
6-O-Oleuropeoylsucrose
6-O-Oleuropeoylsucrose is a constituent of the root bark of the olive (Olea europaea). Constituent of the root bark of the olive (Olea europaea)
Gibberellin A37 glucosyl ester
Gibberellin A37 glucosyl ester (GA37 glucosyl ester) belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated. Gibberellin A37 glucosyl ester is found in pulses. Gibberellin A37 glucosyl ester is a constituent of the seeds of Phaseolus vulgaris (kidney beans). Constituent of the seeds of Phaseolus vulgaris (kidney beans). Gibberellin A37 glucosyl ester is found in pulses, yellow wax bean, and green bean.
Acetyl-T2 Toxin
Acetyl-T2 Toxin is a metabolite of Fusarium graminearum, Fusarium poae and Fusarium sporotrichioides. Potential contaminant of cereals. Metabolite of Fusarium graminearum, Fusarium poae and Fusarium sporotrichioides. Potential contaminant of cereals. D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Cafamarine
Cafamarine is found in coffee and coffee products. Cafamarine occurs in coffee. Occurs in coffee. Cafamarine is found in coffee and coffee products.
1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid
C31H32N4O3 (508.24742819999994)
D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
Tert-butyl N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-propan-2-yloxyamino]-1-phenylbutan-2-yl]carbamate
(11S)-11-Benzyl-6-chloro-1,2,10,11,12,13,14,15,16,17,18,19-dodecahydro-5,9-methano-2,5,8,10,13,17-benzohexaazacyclohenicosine-3,24-dione
Difluprednatum
C27H34F2O7 (508.22724780000004)
Belnacasan
C24H33ClN4O6 (508.20885080000005)
(1R,3R)-5-[(2E)-2-[(3As,7aS)-7a-methyl-1-[(Z,2R)-7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)hept-4-en-2-yl]-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
C26H34F6O3 (508.24120059999996)
Kushenol M
Kushenol M is a natural product found in Sophora flavescens with data available.
Tanariflavanone A
A hydroxyflavanone with a pyranochromane skeleton that is 3,4,7,8-tetrahydro-2H,6H-pyrano[3,2-g]chromen-6-one substituted by geminal methyl groups at position 2, hydroxy groups at positions 3 and 5 and a phenyl group at position 8 which in turn is substituted by a geranyl group at position 2 and hydroxy groups at positions 3 and 4. Isolated from Macaranga tanarius, it exhibits alleopathic effect.
Petalostemumol
Mortonin C
Tanariflavanone C
A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5,7, 3 and 4, a geranyl group at position 2 and a 2-hydroxy-3-methylbut-3-en-1yl group at position 6. Isolated from Macaranga tanarius, it exhibits radical scavenging activity.
Mortonin D
[(3R,3aS,4R,6R,8S,9bR)-6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-8-yl] (E)-2-methylbut-2-enoate
(12R)-12-cinnamoyloxy-3beta,5-dihydroxy-8,14-seco-5beta,17beta-pregn-6-ene-8,14,20-trione|cynaphyllogenin|Cynaphylloside
(4bS,8aS)-4b,5,6,8a,9,10-hexahydro-4-hydroxy-7-(hydroxymethyl)-2-(2-hydroxypropyl)-4b,8-dimethyl-10-oxophenanthren-3-yl beta-D-glucopyranoside|12-[(beta-D-glucopyranosyl)oxy]-11,16,18-trihydroxy-17(15->16)-18(4->3)-abeo-abieta-3,8,11,13-tetraen-7-one|clerodendranthuside C
(-)-(7S,7S,8R,8S,8R)-4,4-dihydroxy-3,3,5-trimethoxy-4,8-oxy-2,7-cyclo-8,8-sesquineolignan-7-ol
A neolignan isolated from the barks of Machilus robusta.
2beta,10beta,11alpha-triacetoxy-8alpha-(2-methylbutanoyloxy)-slov-3-enolide
1alpha,7beta-diacetoxy-5alpha-hydroxy-12alpha-methoxycass-13(15)-en-16,12-olide-17beta-carboxylate
4alpha,5alpha-diacetoxy-9alpha-benzoyloxy-7betaH-eudesman-1beta,2beta,11, 14-tetraol
9alpha-(2-methylbutyryloxy)-4beta,15-epoxyrepandanolide-8-O-(5-hydroxyangelate)|9alpha-<2-methylbutyryloxy>-4beta,15-epoxyrepandanolide-8-O-<5-hydroxyangelate>
(3R,5R)-3,5-Dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)heptane 3-O-??-D-glucopyranoside
8R,8R-(-)-secoisolariciresinol-4-O-alpha-L-rhamnoside|secoisolariciresinol-4-O-alpha-L-rhamnoside
michaolide I
A cembrane diterpenoid with cytotoxic activity isolated from the soft coral Lobophytum michaelae.
2beta-O-beta-D-glucopyranosyl-6-deoxy-solidagolactone IV-18,19-olide
(-)-4-deacetyljunceellolide D|4-deacetyljunceellolide D
(2R)-2-[(S)-3-hydroxy-3-methylglutaryloxy]putrescine dicinnamamide|pholiotic acid
(12S)-1beta,6alpha,19-triacetoxy-12-hydroxy-4,18-epoxyneoclerod-13(14)-en-15,16-olide|ajugalide B|ajugalide-B|ajugamarin C1
(E)-2,3-dihydro-4-hydroxy-2-(1-hydroxy-1-methylethyl)-7,8-dimethoxy-6-(3,7-dimethyl-2,6-octadienyl)-5H-furo[3,2-b]xanthen-5-one|oliverixanthone
Asp Phe Val Glu
Val Glu Phe Asp
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
Indacaterol Maleate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Indacaterol maleate (QAB149) is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol maleate inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol maleate can also be used in cardiovascular disease research[1][2].
MLS001148580-01!6ALPHA,9ALPHA-DIFLUOROPREDNISOLONE 21-ACETATE 17-BUTYRATE
C27H34F2O7 (508.22724780000004)
C26H36O10_2-Butenoic acid, 2-methyl-, (3R,3aS,4R,6R,8S,9bR)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-8-yl ester, (2E)
[(3R,3aS,4R,6R,8S,9bR)-6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-8-yl] (E)-2-methylbut-2-enoate_major
[(3R,3aS,4R,6R,8S,9bR)-6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-8-yl] (E)-2-methylbut-2-enoate_0.8\\%
Ala Gln Gln Tyr
C22H32N6O8 (508.22815119999996)
Ala Gln Tyr Gln
C22H32N6O8 (508.22815119999996)
Ala Tyr Gln Gln
C22H32N6O8 (508.22815119999996)
Cys Cys Lys Arg
Cys Cys Arg Lys
Cys His His Ile
Cys His His Leu
Cys His Ile His
Cys His Leu His
Cys Ile His His
Cys Lys Cys Arg
Cys Lys Met Gln
Cys Lys Gln Met
Cys Lys Arg Cys
Cys Leu His His
Cys Met Lys Gln
Cys Met Gln Lys
Cys Gln Lys Met
Cys Gln Met Lys
Cys Arg Cys Lys
Cys Arg Lys Cys
Asp Asp Phe Ile
Asp Asp Phe Leu
Asp Asp Ile Phe
Asp Asp Leu Phe
Asp Glu Phe Val
Asp Glu Val Phe
Asp Phe Asp Ile
Asp Phe Asp Leu
Asp Phe Glu Val
Asp Phe Ile Asp
Asp Phe Leu Asp
Asp His His Thr
Asp His Thr His
Asp Ile Asp Phe
Asp Ile Phe Asp
Asp Ile Met Met
Asp Leu Asp Phe
Asp Leu Phe Asp
Asp Leu Met Met
Asp Met Ile Met
Asp Met Leu Met
Asp Met Met Ile
Asp Met Met Leu
Asp Thr His His
Asp Val Glu Phe
Asp Val Phe Glu
Glu Asp Phe Val
Glu Asp Val Phe
Glu Phe Asp Val
Glu Phe Val Asp
Glu His His Ser
Glu His Ser His
Glu Met Met Val
Glu Met Val Met
Glu Pro Thr Tyr
Glu Pro Tyr Thr
Glu Ser His His
Glu Thr Pro Tyr
Glu Thr Tyr Pro
Glu Val Asp Phe
Glu Val Phe Asp
Glu Val Met Met
Glu Tyr Pro Thr
Glu Tyr Thr Pro
Phe Asp Asp Ile
Phe Asp Asp Leu
Phe Asp Glu Val
Phe Asp Ile Asp
Phe Asp Leu Asp
Phe Asp Val Glu
Phe Glu Asp Val
Phe Glu Val Asp
Phe Ile Asp Asp
Phe Leu Asp Asp
Phe Asn Gln Thr
C22H32N6O8 (508.22815119999996)
Phe Asn Thr Gln
C22H32N6O8 (508.22815119999996)
Phe Pro Met Asp
Phe Gln Asn Thr
C22H32N6O8 (508.22815119999996)
Phe Gln Gln Ser
C22H32N6O8 (508.22815119999996)
Phe Gln Ser Gln
C22H32N6O8 (508.22815119999996)
Phe Gln Thr Asn
C22H32N6O8 (508.22815119999996)
Phe Ser Gln Gln
C22H32N6O8 (508.22815119999996)
Phe Thr Asn Gln
C22H32N6O8 (508.22815119999996)
Phe Thr Gln Asn
C22H32N6O8 (508.22815119999996)
Phe Val Asp Glu
Phe Val Glu Asp
Gly Asn Arg Tyr
C21H32N8O7 (508.23938419999996)
Gly Asn Tyr Arg
C21H32N8O7 (508.23938419999996)
Gly Arg Asn Tyr
C21H32N8O7 (508.23938419999996)
Gly Arg Tyr Asn
C21H32N8O7 (508.23938419999996)
Gly Tyr Asn Arg
C21H32N8O7 (508.23938419999996)
Gly Tyr Arg Asn
C21H32N8O7 (508.23938419999996)
His Cys His Ile
His Cys His Leu
His Cys Ile His
His Cys Leu His
His Asp His Thr
His Asp Thr His
His Glu His Ser
His Glu Ser His
His His Cys Ile
His His Cys Leu
His His Asp Thr
His His Glu Ser
His His Ile Cys
His His Leu Cys
His His Ser Glu
His His Thr Asp
His Ile Cys His
His Ile His Cys
His Leu Cys His
His Leu His Cys
His Pro Gln Gln
C21H32N8O7 (508.23938419999996)
His Gln Pro Gln
C21H32N8O7 (508.23938419999996)
His Gln Gln Pro
C21H32N8O7 (508.23938419999996)
His Ser Glu His
His Ser His Glu
His Thr Asp His
His Thr His Asp
Ile Cys His His
Ile Asp Asp Phe
Ile Asp Phe Asp
Ile Asp Met Met
Ile Phe Asp Asp
Ile His Cys His
Ile His His Cys
Ile Met Asp Met
Ile Met Met Asp
Lys Cys Cys Arg
Lys Cys Met Gln
Lys Cys Gln Met
Lys Cys Arg Cys
Lys Met Cys Gln
Lys Met Gln Cys
Lys Gln Cys Met
Lys Gln Met Cys
Lys Arg Cys Cys
Leu Cys His His
Leu Asp Asp Phe
Leu Asp Phe Asp
Leu Asp Met Met
Leu Phe Asp Asp
Leu His Cys His
Leu His His Cys
Leu Met Asp Met
Leu Met Met Asp
Met Cys Lys Gln
Met Cys Gln Lys
Met Asp Phe Pro
Met Asp Ile Met
Met Asp Leu Met
Met Asp Met Ile
Met Asp Met Leu
Met Asp Pro Phe
Met Glu Met Val
Met Glu Val Met
Met Phe Asp Pro
Met Phe Pro Asp
Met Ile Asp Met
Met Ile Met Asp
Met Lys Cys Gln
Met Lys Gln Cys
Met Leu Asp Met
Met Leu Met Asp
Met Met Asp Ile
Met Met Asp Leu
Met Met Glu Val
Met Met Ile Asp
Met Met Leu Asp
Met Met Val Glu
Met Pro Val Tyr
Met Pro Tyr Val
Met Gln Cys Lys
Met Gln Lys Cys
Met Val Glu Met
Met Val Met Glu
Met Val Pro Tyr
Met Val Tyr Pro
Met Tyr Pro Val
Met Tyr Val Pro
Asn Phe Gln Thr
C22H32N6O8 (508.22815119999996)
Asn Phe Thr Gln
C22H32N6O8 (508.22815119999996)
Asn Gly Arg Tyr
C21H32N8O7 (508.23938419999996)
Asn Gly Tyr Arg
C21H32N8O7 (508.23938419999996)
Asn Asn Val Tyr
C22H32N6O8 (508.22815119999996)
Asn Asn Tyr Val
C22H32N6O8 (508.22815119999996)
Asn Gln Phe Thr
C22H32N6O8 (508.22815119999996)
Asn Gln Thr Phe
C22H32N6O8 (508.22815119999996)
Asn Arg Gly Tyr
C21H32N8O7 (508.23938419999996)
Asn Arg Tyr Gly
C21H32N8O7 (508.23938419999996)
Asn Thr Phe Gln
C22H32N6O8 (508.22815119999996)
Asn Thr Gln Phe
C22H32N6O8 (508.22815119999996)
Asn Val Asn Tyr
C22H32N6O8 (508.22815119999996)
Asn Val Tyr Asn
C22H32N6O8 (508.22815119999996)
Asn Tyr Gly Arg
C21H32N8O7 (508.23938419999996)
Asn Tyr Asn Val
C22H32N6O8 (508.22815119999996)
Asn Tyr Arg Gly
C21H32N8O7 (508.23938419999996)
Asn Tyr Val Asn
C22H32N6O8 (508.22815119999996)
Pro Glu Thr Tyr
Pro Glu Tyr Thr
Pro His Gln Gln
C21H32N8O7 (508.23938419999996)
Pro Met Val Tyr
Pro Met Tyr Val
Pro Gln His Gln
C21H32N8O7 (508.23938419999996)
Pro Gln Gln His
C21H32N8O7 (508.23938419999996)
Pro Thr Glu Tyr
Pro Thr Tyr Glu
Pro Val Met Tyr
Pro Val Tyr Met
Pro Tyr Glu Thr
Pro Tyr Met Val
Pro Tyr Thr Glu
Pro Tyr Val Met
Gln Ala Gln Tyr
C22H32N6O8 (508.22815119999996)
Gln Ala Tyr Gln
C22H32N6O8 (508.22815119999996)
Gln Cys Lys Met
Gln Cys Met Lys
Gln Phe Asn Thr
C22H32N6O8 (508.22815119999996)
Gln Phe Gln Ser
C22H32N6O8 (508.22815119999996)
Gln Phe Ser Gln
C22H32N6O8 (508.22815119999996)
Gln Phe Thr Asn
C22H32N6O8 (508.22815119999996)
Gln His Pro Gln
C21H32N8O7 (508.23938419999996)
Gln His Gln Pro
C21H32N8O7 (508.23938419999996)
Gln Lys Cys Met
Gln Lys Met Cys
Gln Met Cys Lys
Gln Met Lys Cys
Gln Asn Phe Thr
C22H32N6O8 (508.22815119999996)
Gln Asn Thr Phe
C22H32N6O8 (508.22815119999996)
Gln Pro His Gln
C21H32N8O7 (508.23938419999996)
Gln Pro Gln His
C21H32N8O7 (508.23938419999996)
Gln Gln Ala Tyr
C22H32N6O8 (508.22815119999996)
Gln Gln Phe Ser
C22H32N6O8 (508.22815119999996)
Gln Gln His Pro
C21H32N8O7 (508.23938419999996)
Gln Gln Pro His
C21H32N8O7 (508.23938419999996)
Gln Gln Ser Phe
C22H32N6O8 (508.22815119999996)
Gln Gln Tyr Ala
C22H32N6O8 (508.22815119999996)
Gln Ser Phe Gln
C22H32N6O8 (508.22815119999996)
Gln Ser Gln Phe
C22H32N6O8 (508.22815119999996)
Gln Thr Phe Asn
C22H32N6O8 (508.22815119999996)
Gln Thr Asn Phe
C22H32N6O8 (508.22815119999996)
Gln Tyr Ala Gln
C22H32N6O8 (508.22815119999996)
Gln Tyr Gln Ala
C22H32N6O8 (508.22815119999996)
Arg Cys Cys Lys
Arg Cys Lys Cys
Arg Gly Asn Tyr
C21H32N8O7 (508.23938419999996)
Arg Gly Tyr Asn
C21H32N8O7 (508.23938419999996)
Arg Lys Cys Cys
Arg Asn Gly Tyr
C21H32N8O7 (508.23938419999996)
Arg Asn Tyr Gly
C21H32N8O7 (508.23938419999996)
Arg Tyr Gly Asn
C21H32N8O7 (508.23938419999996)
Arg Tyr Asn Gly
C21H32N8O7 (508.23938419999996)
Ser Glu His His
Ser Phe Gln Gln
C22H32N6O8 (508.22815119999996)
Ser His Glu His
Ser His His Glu
Ser Gln Phe Gln
C22H32N6O8 (508.22815119999996)
Ser Gln Gln Phe
C22H32N6O8 (508.22815119999996)
Thr Asp His His
Thr Glu Pro Tyr
Thr Glu Tyr Pro
Thr Phe Asn Gln
C22H32N6O8 (508.22815119999996)
Thr Phe Gln Asn
C22H32N6O8 (508.22815119999996)
Thr His Asp His
Thr His His Asp
Thr Asn Phe Gln
C22H32N6O8 (508.22815119999996)
Thr Asn Gln Phe
C22H32N6O8 (508.22815119999996)
Thr Pro Glu Tyr
Thr Pro Tyr Glu
Thr Gln Phe Asn
C22H32N6O8 (508.22815119999996)
Thr Gln Asn Phe
C22H32N6O8 (508.22815119999996)
Thr Tyr Glu Pro
Thr Tyr Pro Glu
Val Asp Glu Phe
Val Asp Phe Glu
Val Glu Asp Phe
Val Glu Met Met
Val Phe Asp Glu
Val Phe Glu Asp
Val Met Glu Met
Val Met Met Glu
Val Met Pro Tyr
Val Met Tyr Pro
Val Asn Asn Tyr
C22H32N6O8 (508.22815119999996)
Val Asn Tyr Asn
C22H32N6O8 (508.22815119999996)
Val Pro Met Tyr
Val Pro Tyr Met
Val Tyr Met Pro
Val Tyr Asn Asn
C22H32N6O8 (508.22815119999996)
Val Tyr Pro Met
Tyr Ala Gln Gln
C22H32N6O8 (508.22815119999996)
Tyr Glu Pro Thr
Tyr Glu Thr Pro
Tyr Gly Asn Arg
C21H32N8O7 (508.23938419999996)
Tyr Gly Arg Asn
C21H32N8O7 (508.23938419999996)
Tyr Met Pro Val
Tyr Met Val Pro
Tyr Asn Gly Arg
C21H32N8O7 (508.23938419999996)
Tyr Asn Asn Val
C22H32N6O8 (508.22815119999996)
Tyr Asn Arg Gly
C21H32N8O7 (508.23938419999996)
Tyr Asn Val Asn
C22H32N6O8 (508.22815119999996)
Tyr Pro Glu Thr
Tyr Pro Met Val
Tyr Pro Thr Glu
Tyr Pro Val Met
Tyr Gln Ala Gln
C22H32N6O8 (508.22815119999996)
Tyr Gln Gln Ala
C22H32N6O8 (508.22815119999996)
Tyr Arg Gly Asn
C21H32N8O7 (508.23938419999996)
Tyr Arg Asn Gly
C21H32N8O7 (508.23938419999996)
Tyr Thr Glu Pro
Tyr Thr Pro Glu
Tyr Val Met Pro
Tyr Val Asn Asn
C22H32N6O8 (508.22815119999996)
Tyr Val Pro Met
Acetyl T-2
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Mozambioside
Cafamarine
Gibberellin A37 glucosyl ester
Shikokianin B
6alpha,9-difluoro-11beta-hydroxy-16alpha,17-[isopropylidenebis(oxy)]pregna-1,4-diene-3,20-dione 21-propionate
C27H34F2O7 (508.22724780000004)
1,1,3,3,3,3-hexamethylindotricarbocyanine perchlorate
C29H33ClN2O4 (508.21287280000007)
VX-765
C24H33ClN4O6 (508.20885080000005)
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C38461 - Caspase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-methylheptanoyloxy(7-methyloctanoyloxy)lead
C17H32O4Pb (508.20668820000003)
Argatroban Impurity 26
C23H36N6O5S (508.24677660000003)
Clocortolone Caproate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Lonaprisan
C28H29F5O3 (508.20367439999995)
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist
L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methylvalyl-N-(2-ethoxytetrahydro-5-oxo-3-furanyl)-
C24H33ClN4O6 (508.20885080000005)
2-[[6-(4-morpholinyl)-4-oxo-3-(2-phenylethyl)-2-quinazolinyl]thio]-N-(2-oxolanylmethyl)acetamide
Difluprednate
C27H34F2O7 (508.22724780000004)
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Same as: D01266 Difluprednate is a topical corticosteroid, which is thought to act by the induction of phospholipase A2 inhibitory proteins (lipocortins). Difluprednate is used for the symptomatic treatment of inflammation and pain associated with ocular surgery.
3-Acetyl T-2 toxin
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(E)-N-hydroxy-C-(8-methylsulfanyloctyl)carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
5-[(2E)-2-[7a-methyl-1-[(E)-7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)hept-4-en-2-yl]-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
C26H34F6O3 (508.24120059999996)
20-Benzyl-25-chloro-1,4,14,18,21,23-hexazatricyclo[20.3.1.06,11]hexacosa-6,8,10,22,24-pentaene-3,26-dione
(6S)-1-[4-(dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid
C31H32N4O3 (508.24742819999994)
D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
N-[4-[[2-methoxy-5-[4-oxo-3-(pyridin-4-ylmethyl)-1,2-dihydroquinazolin-2-yl]phenyl]methoxy]phenyl]acetamide
N-[5-(diethylsulfamoyl)-2-(4-morpholinyl)phenyl]-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxamide
1-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea
N-[(3R,3R,4S,5R)-5-(2-hydroxyethyl)-4-[(4-methoxyphenyl)-dimethylsilyl]-3-methyl-2-oxo-1-prop-2-enyl-5-spiro[indole-3,2-oxolane]yl]acetamide
1-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea
N-[(1S,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
1-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea
N-[(1R,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea
(1S)-1-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-N-propyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1S)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(4-oxanylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(4-oxanylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea
N-[(1S,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
(1R)-1-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-N-propyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1R)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
N-[4-[[2-(diethylamino)ethylamino]-oxomethyl]phenyl]-3-[(4-methylphenyl)sulfamoyl]benzamide
2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
(1S,12R,14S,16S,17R)-14,17-dihydroxy-12-methyl-17-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-8-oxapentacyclo[14.2.1.01,13.04,12.05,9]nonadeca-5(9),6-dien-10-one
Acetyl-T2 Toxin
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid
C31H32N4O3 (508.24742819999994)
D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
BI-1622
C26H24N10O2 (508.20836039999995)
BI-1622 is an orally active, potent and highly selective HER2 (ERBB2) inhibitor, with an IC50 of 7 nM. BI-1622 shows greater than 25-fold selectivity over EGFR. BI-1622 shows high antitumor efficacy in vivo in xenograft mouse tumor models with engineered H2170 and PC9 cells and had a favorable agent metabolism and pharmacokinetics profile[1].
5,7-bis(acetyloxy)-2-hydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl acetate
5-(acetyloxy)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-2,7-dioxo-1h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(1r,3br,4s,5r,5ar,9as,9br,11as)-4-(acetyloxy)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-2,7-dioxo-1h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
{3-hydroxy-4-[(2s)-2-hydroxy-6-methylheptan-2-yl]phenyl}methyl 2-hydroxy-4-(3-hydroxy-5-methylphenoxy)-6-methylbenzoate
(1r,2s)-2-{[(2s,3s)-2-hydroxy-2-methyl-3-[(3-methylbutanoyl)oxy]butanoyl]oxy}-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)propyl 3-methylbut-2-enoate
1-hydroxy-4-(hydroxymethyl)-8,8,11a-trimethyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,6h,7h,7ah,9h,10h,11h-phenanthro[3,4-c]furan-3-one
2-{[5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)heptan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3'r,4'ar,5's,6'r,6'ar,10'ar,10'br)-5',6'-bis(acetyloxy)-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'a-ylmethyl acetate
(2r,3r,4s,5s,6r)-2-{[(3r,5r)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)heptan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(9r)-3,4,5,19-tetramethoxy-9,10-dimethyl-8-phenoxy-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-9-ol
(1s,2s,7r,8r,9s,10s,12s,13s,16r)-8,10-bis(acetyloxy)-4,12,13-trihydroxy-5,9-dimethyl-2-(prop-1-en-2-yl)-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-4-en-7-yl acetate
(1r,2r,3s,4r,5s,7s,8s,9s,12z,14s,17r)-5,7-bis(acetyloxy)-2-hydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl acetate
2-[3,4-dihydroxy-2,6-bis(3-methylbut-2-en-1-yl)phenyl]-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
5',6'-bis(acetyloxy)-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'a-ylmethyl acetate
(1s,2s,3s,4r,5r,6s)-2,5-dihydroxy-3,4,6-tris({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl (2z)-2-methylbut-2-enoate
[12,14-bis(acetyloxy)-2,3-dihydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-9-yl]methyl acetate
2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-4-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl acetate
(1r,2s)-2-({2-hydroxy-2-methyl-3-[(3-methylbutanoyl)oxy]butanoyl}oxy)-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)propyl 3-methylbut-2-enoate
(1r,2s,3s,4r,5r,6s)-2,4-dihydroxy-3,5,6-tris({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl (2z)-2-methylbut-2-enoate
[(1s,2r,3r,4r,7s,8e,12s,13s,14s)-12,14-bis(acetyloxy)-2,3-dihydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-9-yl]methyl acetate
4-[2-(7,8-dimethyl-3-oxo-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-7-yl)ethyl]-5h-furan-2-one
(1s,2r,3s,4r,5r,7s,8s,9r,12z,14s,17r)-7,9-bis(acetyloxy)-5-hydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-2-yl acetate
(1s,2s,3r,4r,5r,6s)-3,5-dihydroxy-2,4,6-tris({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl (2z)-2-methylbut-2-enoate
1-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-6-hydroxy-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-5-yl]-2-(5-oxo-2h-furan-3-yl)ethyl acetate
2-({2-hydroxy-2-methyl-3-[(3-methylbutanoyl)oxy]butanoyl}oxy)-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)propyl 3-methylbut-2-enoate
[(5ar,7ar,8r,9s,11as,11br)-9-(acetyloxy)-5a,8,11a-trimethyl-1-oxo-3-phenyl-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-8-yl]methyl acetate
(1s,2r,3s,4s,5r,6r)-2,5-dihydroxy-3,4,6-tris({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl (2z)-2-methylbut-2-enoate
(2s)-2-[(2s)-2-[(1-hydroxyethylidene)amino]-n-methyl-3-phenylpropanamido]-n-[(1z)-2-(1h-indol-3-yl)ethenyl]-3-phenylpropanimidic acid
C31H32N4O3 (508.24742819999994)